2014
DOI: 10.1016/j.fertnstert.2014.02.020
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
31
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(44 citation statements)
references
References 27 publications
4
31
0
1
Order By: Relevance
“…Of 41 full-text reports eligible for the review, 22 were casecontrol studies, 18 were cross-sectional studies, and one cohort study (phase of initial evaluation; Supplemental Table 3). Of all selected studies, two publications reported two cohorts, which we analyzed separately: Ma et al reported both on PCOS subjects identified in referral and unselected cohorts from one center in China (34); and de Guevara reported on patients with PCOS in two referral cohorts from Chile and Argentina (28). Thus, 43 populations were available for meta-analysis of the prevalence of PCOS phenotypes.…”
Section: Study Characteristicsmentioning
confidence: 99%
“…Of 41 full-text reports eligible for the review, 22 were casecontrol studies, 18 were cross-sectional studies, and one cohort study (phase of initial evaluation; Supplemental Table 3). Of all selected studies, two publications reported two cohorts, which we analyzed separately: Ma et al reported both on PCOS subjects identified in referral and unselected cohorts from one center in China (34); and de Guevara reported on patients with PCOS in two referral cohorts from Chile and Argentina (28). Thus, 43 populations were available for meta-analysis of the prevalence of PCOS phenotypes.…”
Section: Study Characteristicsmentioning
confidence: 99%
“…It presents chronic anovulation (oligomenorrhea or amenorrhea), androgen excess (biochemical or clinical symptoms, in our study biochemical) and polycystic ovary in ultrasound examination [5]. This phenotype presents more frequent and severe metabolic disorders such as visceral obesity, non-alcoholic fatty liver, insulin resistance and dyslipidemia in comparison to other PCOS phenotypes [5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…La prevalencia del síndrome metabólico (SM) ha aumentado en la población general, con reportes de hasta un 25% en Europa y Norteamérica, incrementando la posibilidad de desarrollar diabetes tipo 2 y enfermedades cardiovasculares, al catalogarse como un poderoso factor de riesgo para dichas patologías. Su asociación con el SOP ha presentado una frecuencia variable, con una menor prevalencia en las mujeres del Este Asiático y una mayor, en las mujeres africanas, hispanas y del Sur de Asia (31,32).…”
Section: Síndrome Metabólicounclassified